Evaluation of the impact of nasal colonization with methicillin-resistant Staphylococcus aureus on left ventricular assist device infections.

Autor:	Koscal LJ; Department of Pharmacy, University of Florida Health at Jacksonville, Jacksonville, Florida., Meadows H; Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina., Raux BR; Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina., Mediwala KN; Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina., Weeda E; Medical University of South Carolina, College of Pharmacy, Charleston, South Carolina., Houston B; Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina., Jandhyala D; Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina., Hawn JM; Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina.
Jazyk:	angličtina
Zdroj:	Antimicrobial stewardship & healthcare epidemiology : ASHE [Antimicrob Steward Healthc Epidemiol] 2022 May 10; Vol. 2 (1), pp. e79. Date of Electronic Publication: 2022 May 10 (Print Publication: 2022).
DOI:	10.1017/ash.2022.46
Abstrakt:	In this retrospective cohort study, we evaluated the predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swabs for the development of MRSA infections in patients with left ventricular assist devices. In 106 patients, the MRSA nasal swab had a negative predictive value of 92.9% demonstrating a potential role in antibiotic de-escalation. (© The Author(s) 2022.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu